Dana Farber Cancer Institute, Attn: Vasilika Koci, PharmD — Boston, Massachusetts

Dana Farber Cancer Institute, Attn: Vasilika Koci, PharmD is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Institute, Attn: Vasilika Koci, PharmD has participated in 1 clinical trials.

Therapeutic areas: Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Institute, Attn: Vasilika Koci, PharmD?

Dana Farber Cancer Institute, Attn: Vasilika Koci, PharmD has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Institute, Attn: Vasilika Koci, PharmD conducted?

Dana Farber Cancer Institute, Attn: Vasilika Koci, PharmD has 1 clinical trials on record. Their work covers Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors.

Is Dana Farber Cancer Institute, Attn: Vasilika Koci, PharmD accredited by Crixeo Health?

Dana Farber Cancer Institute, Attn: Vasilika Koci, PharmD has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Institute, Attn: Vasilika Koci, PharmD?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.